SCHEMBL30120742

SCHEMBL30120742

COc1ccc(CNc2nccc3c2c(-c2ccc4c(c2F)CCN4C(=O)Cc2cc(C(F)(F)F)ccc2F)nn3C2CC2)c(OC)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCRL2 O00421 1/20 0.37
▸ EIF2AK3 Q9NZJ5 2/20 0.35
▸ CSF1R P07333 2/20 0.34
▸ CYP1A2 P05177 2/20 0.34
▸ CYP3A4 P08684 2/20 0.34
▸ ALOX15 P16050 2/20 0.34
▸ TSHR P16473 2/20 0.34
▸ CYP2C19 P33261 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ USP2 O75604 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ P2RX3 P56373 1/20 0.33
▸ LIPE Q05469 1/20 0.33
▸ HDAC3 O15379 1/20 0.33
▸ HDAC1 Q13547 1/20 0.33
▸ HDAC2 Q92769 1/20 0.33
▸ HDAC6 Q9UBN7 1/20 0.33
▸ HCRTR1 O43613 1/20 0.32
▸ HCRTR2 O43614 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24651193 1.00 CCRL2 (0.37) CCRL2EIF2AK3CSF1RCYP1A2CYP3A4
SCHEMBL24651054 0.82 EIF2AK3 (0.43) EIF2AK3CSF1RCYP1A2CYP3A4CYP2C19
SCHEMBL30120820 0.82 EIF2AK3 (0.43) EIF2AK3CSF1RCYP1A2CYP3A4CYP2C19
SCHEMBL30367510 0.73 BTK (0.41) KMT2A
SCHEMBL29998362 0.70 EGFR (0.41) CYP1A2CYP3A4ALOX15TSHRCYP2C19
SCHEMBL24096504 0.70 EGFR (0.41) CYP1A2CYP3A4ALOX15TSHRCYP2C19
SCHEMBL24651143 0.70 CYP1A2 (0.46) CYP1A2CYP3A4ALOX15TSHRCYP2C19
SCHEMBL24650695 0.70 EIF2AK3 (0.47) EIF2AK3CYP1A2CYP3A4CYP2C19CYP2D6
SCHEMBL30120848 0.70 EIF2AK3 (0.47) EIF2AK3CYP1A2CYP3A4CYP2C19CYP2D6
SCHEMBL24651144 0.69 NPC1 (0.43) CYP1A2CYP3A4ALOX15TSHRCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022212326-A1 NEK7 INHIBITORS Halia Therapeutics, Inc. (US) 2022-10-06 — — WO disclosed
Send feedback